Back to results
TerminatedPhase 1

Safety Evaluation of Intravenous Talineuren (TLN) in Parkinson's Disease-affected Patients

NCT04976127

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Neurologisches Institut Konolfingen

Konolfingen, Canton of Bern, Switzerland

View on ClinicalTrials.gov
Safety Evaluation of Intravenous Talineuren (TLN) in Parkinson's Disease-affected Patients — TrialFind